November 8, 2026
Breaking
Business

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

admin1 min read
Getting your Trinity Audio player ready...

Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.

The post Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production appeared first on Business News.

Leave a Comment

Your email address will not be published. Required fields are marked *